Cargando…

Effects of N6-Methyladenosine Regulators on LAG3 and Immune Infiltrates in Lung Adenocarcinoma

BACKGROUND: Lung adenocarcinoma (LUAD) is the most common histological subtype of lung cancer, which is one of the most commonly diagnosed tumors and the leading causes of death from cancer around the world. Since RNA methylation is a posttranscriptional modification and affects so much biological p...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wang, Nengchao, Xu, Yue, Jin, Linzhi, Wang, Xiaomin, Wu, Shouxin, Wang, Yu, Zhao, Jiangman, Zhou, Fuyou, Ge, Hong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi 2022
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9427291/ https://www.ncbi.nlm.nih.gov/pubmed/36051357 http://dx.doi.org/10.1155/2022/1829528

Ejemplares similares

Immune Infiltration and N(6)-Methyladenosine ncRNA Isoform Detection in Acute Lung Injury
por: Gu, Chenzheng, et al.
Publicado: (2022)

Analysis of N6-Methyladenosine Modification Patterns and Tumor Immune Microenvironment in Pancreatic Adenocarcinoma
por: Liu, Yong, et al.
Publicado: (2022)

Genomics and Prognosis Analysis of N(6)-Methyladenosine Regulators in Lung Adenocarcinoma
por: Ma, Yanpin, et al.
Publicado: (2021)

Deciphering N(6)-Methyladenosine-Related Genes Signature to Predict Survival in Lung Adenocarcinoma
por: Zhu, Jie, et al.
Publicado: (2020)

RNA N6-Methyladenosine Regulator-Mediated Methylation Modifications Pattern and Immune Infiltration Features in Glioblastoma
por: Pan, Yimin, et al.
Publicado: (2021)

Significance of N6-Methyladenosine RNA Methylation Regulators in Immune Infiltrates of Ovarian Cancer
por: Gu, Jing, et al.
Publicado: (2021)

Development and Validation of a Prognostic N6-Methyladenosine-Related Immune Gene Signature for Lung Adenocarcinoma
por: Zhang, Lemeng, et al.
Publicado: (2021)

Research Progress of N6-Methyladenosine in the Cardiovascular System
por: Zheng, Nan, et al.
Publicado: (2020)

N6-Methyladenosine Regulators Promote Malignant Progression of Gastric Adenocarcinoma
por: Zhao, Yibin, et al.
Publicado: (2022)

RNA N(6)-Methyladenosine Modifications and the Immune Response
por: Wang, Ya-Nan, et al.
Publicado: (2020)

Tumor stemness and immune infiltration synergistically predict response of radiotherapy or immunotherapy and relapse in lung adenocarcinoma
por: Shi, Hongjie, et al.
Publicado: (2021)

N6-methyladenosine methylation modification patterns reveal immune profiling in pancreatic adenocarcinoma
por: Xu, Hao, et al.
Publicado: (2022)

Identification of the relationship between single-cell N6-methyladenosine regulators and the infiltrating immune cells in esophageal carcinoma
por: Bian, Yunyi, et al.
Publicado: (2023)

An N6-Methyladenosine-Related Gene Set Variation Score as a Prognostic Tool for Lung Adenocarcinoma
por: Zhang, Huijuan, et al.
Publicado: (2021)

Analysis of N(6)-Methyladenosine Methylome in Adenocarcinoma of Esophagogastric Junction
por: Huang, Jia-Bin, et al.
Publicado: (2022)

IGF2BP3 is an essential N(6)-methyladenosine biotarget for suppressing ferroptosis in lung adenocarcinoma cells
por: Xu, Xin, et al.
Publicado: (2022)

N6-methyladenosine with immune infiltration and PD-L1 in hepatocellular carcinoma: novel perspective to personalized diagnosis and treatment
por: Shi, Yanlong, et al.
Publicado: (2023)

Prediction of prognosis, immune infiltration and immunotherapy response with N6-methyladenosine-related lncRNA clustering patterns in cervical cancer
por: Jia, Haixia, et al.
Publicado: (2022)

Target genes of N6-methyladenosine regulatory protein ALKBH5 are associated with prognosis of patients with lung adenocarcinoma
por: Jiang, Long, et al.
Publicado: (2023)

N6-Methyladenosine-Regulated mRNAs: Potential Prognostic Biomarkers for Patients With Lung Adenocarcinoma
por: Sun, Junjun, et al.
Publicado: (2021)

N6-methyladenosine (m6A)-connected lncRNAs are linked to survival and immune infiltration in glioma patients
por: Wu, Wei Jun, et al.
Publicado: (2023)

Comprehensive Analysis of N6-Methyladenosine (m(6)A) RNA Methylation Regulators and Tumour Microenvironment Cell Infiltration Involving Prognosis and Immunotherapy in Gastroesophageal Adenocarcinomas
por: Liu, Duanrui, et al.
Publicado: (2022)

N6-Methyladenosine Regulator-Mediated Immue Patterns and Tumor Microenvironment Infiltration Characterization in Glioblastoma
por: Xiong, Wu, et al.
Publicado: (2022)

Comprehensive analysis of the PD-L1 and immune infiltrates of N6-methyladenosine related long non-coding RNAs in bladder cancer
por: Xue, M. Q., et al.
Publicado: (2022)

The YTH Domain Family of N6-Methyladenosine “Readers” in the Diagnosis and Prognosis of Colonic Adenocarcinoma
por: Xu, Dian, et al.
Publicado: (2020)

Relationships of N6-Methyladenosine-Related Long Non-Coding RNAs With Tumor Immune Microenvironment and Clinical Prognosis in Lung Adenocarcinoma
por: Zhao, Jianhui, et al.
Publicado: (2021)

The Non-N(6)-Methyladenosine Epitranscriptome Patterns and Characteristics of Tumor Microenvironment Infiltration and Mesenchymal Transition in Glioblastoma
por: Xu, Jianye, et al.
Publicado: (2022)

Immune infiltration-related N6-methyladenosine RNA methylation regulators influence the malignancy and prognosis of endometrial cancer
por: Ma, Jian, et al.
Publicado: (2021)

Potential roles of N6-methyladenosine (m6A) in immune cells
por: Liu, Chang, et al.
Publicado: (2021)

N(6)-Methyladenosine and Viral Infection
por: Dang, Wei, et al.
Publicado: (2019)

Emerging role of RNA modification N6-methyladenosine in immune evasion
por: Lou, Xin, et al.
Publicado: (2021)

Regulation of Antiviral Immune Response by N(6)-Methyladenosine of mRNA
por: Zhao, Baoxin, et al.
Publicado: (2021)

Targeting RNA N6-methyladenosine to synergize with immune checkpoint therapy
por: Zhou, Xianyong, et al.
Publicado: (2023)

The Important Role of N6-methyladenosine RNA Modification in Non-Small Cell Lung Cancer
por: Cheng, Yue, et al.
Publicado: (2021)

The emerging roles and mechanism of N6-methyladenosine (m(6)A) modifications in urologic tumours progression
por: Zhu, Wenhao, et al.
Publicado: (2023)

Importance of N(6)-methyladenosine RNA modification in lung cancer (Review)
por: Wang, Yueyang, et al.
Publicado: (2021)

Research advances of N6‐methyladenosine in diagnosis and therapy of pancreatic cancer
por: Chen, Sai, et al.
Publicado: (2022)

Impact of N6-methyladenosine (m(6)A) modification on immunity
por: Elsabbagh, Raghda A., et al.
Publicado: (2022)

Analysis approaches for the identification and prediction of N(6)-methyladenosine sites
por: Yang, Yuwei, et al.
Publicado: (2022)

N6-Methyladenosine-Related Gene Signature Associated With Monocyte Infiltration Is Clinically Significant in Gestational Diabetes Mellitus
por: Du, Runyu, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_02to6shotfck5qn7gj9dp40g9h